Effectdossier · gearchiveerd kwartaal
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
21Gevolgde houders
+1Δ houders
60.08MGehouden aandelen
$24.19BGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.0% ·
aandelenstroom +3.2% ·
netto nieuwe posities +4.8%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.02M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
Wie het bezit · Q4 2024
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 28.33M | +5.7% | $11.41B | 1.7% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passief) | 11.98M | — | $4.82B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 5.65M | -4.8% | $2.27B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 5.65M | -4.8% | $2.27B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (passief) | 3.41M | +0.1% | $1.37B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.69M | -4.4% | $680.85M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 1.69M | -4.4% | $680.85M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 1.40M | -14.4% | $562.66M | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 310.64K | +95.0% | $125.10M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 265.68K | +92.0% | $106.99M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 265.68K | +92.0% | $106.99M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 209.24K | -39.6% | $84.26M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 194.00K | -20.5% | $78.12M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 27 | Marshall Wace ✦ | 194.00K | -20.5% | $78.12M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 162.18K | +222.9% | $65.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 162.18K | +222.9% | $65.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 33 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | Tweedy, Browne ✦ | 40.63K | -24.2% | $16.36M | 1.1% | ▼ Trim | 3 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 33.16K | -79.3% | $13.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | Gotham Asset Management ✦ | 30.11K | +11.0% | $12.13M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 37 | Fisher Asset Management ✦ | 29.91K | +10.7% | $12.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | ARK Investment Management ✦ | 25.35K | -50.4% | $10.21M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 39 | Arrowstreet Capital ✦ | 9.27K | Nieuw | $3.73M | 0.0% | New | 1 | SEC ↗ |
| 40 | Bridgewater Associates ✦ | 710 | -79.4% | $285,917 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Arrowstreet Capital | $3.73M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,678 houders, 225.07M aandelen, $98.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2024 ·
Methodologie ·
Verkrijg dit via de API